Cargando...
The RAF Inhibitor Paradox Revisited
The success of the RAF protein kinase inhibitor vemurafenib for the treatment of BRAF-mutant metastatic melanoma has produced another poster child for the promise of personalized medicine. However, the results of a recent study also reveal unexpected pitfalls in the application of signal transductio...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2012
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3285264/ https://ncbi.nlm.nih.gov/pubmed/22340588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2012.01.017 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|